Headline Details

Drugmakers see a pricing blueprint in an $850,000 gene therapy

Published on: Fri, 12 Jan 2018 20:32:34 UTC
News Agency: Reuters
Description:
SAN FRANCISCO (Reuters) - Global drugmakers are looking to a tiny biotech's $850,000 therapy for a rare type of blindness as a model for getting paid for highly expensive – and effective – new medicines.

Click here for FULL Story on Reuters

Also happening now

HeadlineNews Agency
China state paper accuses west of double standards on Xinjiang Reuters
Brazil far-right candidate extends lead over leftist rival ahead of run-off: poll Reuters
Sabarimala: The Indian god who bars women from his temple BBC
Afghanistan election: What's at stake in the parliament vote? BBC
Jamal Khashoggi: Who's who in alleged Saudi 'hit squad' BBC